ULTRAGENYX PHARMACEUTICAL IN's ticker is RARE and the CUSIP is 90400D108. A total of 238 filers reported holding ULTRAGENYX PHARMACEUTICAL IN in Q2 2021. The put-call ratio across all filers is 1.29 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $2,427,000 | -22.7% | 26,908 | -18.2% | 0.08% | -25.0% |
| Q2 2021 | $3,139,000 | -16.7% | 32,911 | -0.5% | 0.10% | -21.8% |
| Q1 2021 | $3,769,000 | -10.3% | 33,092 | +9.0% | 0.13% | -7.0% |
| Q4 2020 | $4,204,000 | +30.6% | 30,365 | -22.5% | 0.14% | +36.2% |
| Q3 2020 | $3,219,000 | +425.1% | 39,188 | +212.2% | 0.10% | +483.3% |
| Q2 2016 | $613,000 | -10.8% | 12,552 | +15.7% | 0.02% | -14.3% |
| Q1 2016 | $687,000 | +37.1% | 10,852 | +143.3% | 0.02% | +50.0% |
| Q4 2015 | $501,000 | +13.9% | 4,461 | -2.3% | 0.01% | +7.7% |
| Q3 2015 | $440,000 | – | 4,567 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| First Light Asset Management, LLC | 437,512 | $31,772,000 | 2.80% |
| RTW INVESTMENTS, LP | 1,373,284 | $99,728,000 | 2.06% |
| Rock Springs Capital Management LP | 1,028,109 | $74,661,000 | 1.88% |
| Privium Fund Management B.V. | 112,727 | $8,186,000 | 1.81% |
| Avidity Partners Management LP | 869,000 | $63,107,000 | 1.31% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 525,100 | $38,133,000 | 1.16% |
| Boxer Capital, LLC | 200,000 | $14,524,000 | 0.75% |
| SECTOR GAMMA AS | 46,221 | $3,357,000 | 0.73% |
| FEDERATED HERMES, INC. | 3,987,728 | $289,589,000 | 0.65% |
| EMERALD ADVISERS, LLC | 223,952 | $16,263,000 | 0.62% |